Danimer Scientific, Inc. announced impairment charges for the fourth quarter ended December 31, 2023. For the quarter, the company reported Impairment of long-lived assets of $188,000.
Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
0.7985 USD | +5.37% | -0.67% | -21.72% |
May. 07 | Transcript : Danimer Scientific, Inc., Q1 2024 Earnings Call, May 07, 2024 | |
May. 07 | Earnings Flash (DNMR) DANIMER SCIENTIFIC Reports Q1 Revenue $10.2M, vs. Street Est of $10.7M | MT |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-21.72% | 88.23M | |
+8.33% | 41.78B | |
-21.64% | 21.93B | |
-13.26% | 13.45B | |
-9.15% | 10.2B | |
-7.18% | 9.8B | |
+16.55% | 8.02B | |
+9.81% | 6.91B | |
-26.59% | 5.78B | |
-27.09% | 3.37B |
- Stock Market
- Equities
- DNMR Stock
- News Danimer Scientific, Inc.
- Danimer Scientific, Inc. Announces Impairment Charges for the Fourth Quarter Ended December 31, 2023